麻豆传媒

Dr. Alfonso Torquati, an internationally renowned expert in metabolic and weight loss surgery, is the chairperson of the Department of General Surgery at Rush University Medical Center. He also leads the Center for Weight Loss and Bariatric Surgery, which

Johnston is Professor and Associate Director of the Nutrition Program in the School of Nutrition and Health Promotion at Arizona State University. She chairs the Institutional Review Board at ASU which oversees human subject research at the university.

Dr. Tardif is Associate Director of Research and Senior Management Team member for SNPRC and has extensive experience coordinating large, integrated research projects throughout her professional career. She served as the marmoset expert for the team charged with sequencing the marmoset genome and as the species expert for recent studies on development of induced pluripotent stem cell (iPS cell) technologies. Her research is focused on metabolism, behavior and reproduction and, most recently, on the characterization of the marmoset as a model for obesity and aging. Dr. Tardif has more than 30 years of expertise in the development of common marmoset monkeys as biomedical models in diverse areas including: Reproductive biology Infectious disease Neuroscience Aging and obesity

Dr. Alain Dagher is a neurologist specializing in movement disorders and functional brain imaging. His research aims at understanding the function of the basal ganglia, with a particular emphasis on appetitive behaviours. This involves studying how we learn about rewards and punishments, and become motivated to engage in reward-seeking behaviour. The two main techniques used are positron emission tomography (PET) targeting the dopamine system, and functional magnetic resonance imaging (fMRI). The research focusses on Parkinson's Disease, stress, drug addiction (notably cigarette smoking), pathological gambling, and obesity. Dr. Dagher is funded by CIHR, FRSQ, NIDA, the Parkinson Society of Canada, the Institute for Research on Pathological Gambling and Related Disorders, and Unilever PLC.

The long-term goal of our research program is to elucidate mechanisms of obesity-associated coronary microvascular dysfunction and thereby identify novel pathways and therapeutic targets to reduce cardiovascular complications in these patients. The central premise of our work is that coronary microvascular dysfunction and the resultant impairment of coronary blood flow control is an independent predictor of cardiovascular morbidity and mortality in obese, diabetic patients. Impaired coronary microvascular function is estimated to account for more than 60% of cardiac perfusion defects in patients with type 2 diabetes. Thus, coronary microvascular dysfunction is a significant contributor to impaired cardiac function, ischemia, infarct, and mortality in these patients.

Current projects in the laboratory focus on the role of the aldosterone-binding mineralocorticoid receptor (MR) as a mediator of coronary and cardiac dysfunction in obesity. A growing body of evidence has implicated MR signaling in vascular cells as an important mediator of vascular and cardiac dysfunction in various disease states. Our studies utilize an integrative combination of in vivo and in vitro approaches including cell/tissue culture and clinically relevant mouse models coupled with molecular techniques.

---

Glenn Gaesser is an expert in the impact of exercise, diet and cardiovascular health.

Gaesser's work has included exercise training interventions, muscular efficiency, and oxygen uptake during and after exercise. He's an advocate of breaking long periods of stagnance with physical activity. He speaks on the notion of health at any size, supporting a non-weight-loss-centered approach to treating obesity-related health issues. Metabolic efficiency and dietary habits are a major part of his work.

Gaesser is the center director for the College of Health Solution and a professor of Exercise Physiology.

He has served as the Southwest Chapter of the American College of Sports Medicine. He has also worked with the Center for Disease Control and has collaborated with NASA as well.

Elliot Berkman is a professor of psychology at the University of Oregon and Co-Director of the Center for Translational Neuroscience. He studies the motivational and cognitive factors that contribute to success and failure at health goals such as cigarette smoking cessation and dieting. His research leverages the distinct strengths of several research methods, including functional magnetic resonance imaging, longitudinal survey methods, and laboratory experiments.

This work adopts a translational neuroscience approach by using knowledge of brain function, structure, and connectivity to design and improve interventions on health behavior and wellbeing. Projects in the lab are currently funded by the National Cancer Institute and the National Institute on Drug Abuse. He directs the Social and Affective Neuroscience Laboratory in the Department of Psychology.

A Boston-area resident, Anderson-Haynes is the founder and owner of a private practice specializing in holistic health and wellness for females. She鈥檚 certified in adult weight management, a certified personal trainer and a certified diabetes care and education specialist. She graduated from the University of Florida and Andrews University.

Santo Coleman’s areas of research are men’s health and masculinity across the lifespan, including adolescent health and fatherhood. Currently, his focus is the effect of gender on health behavior outcomes such as obesity. Additionally, he examines the role of culture on gender performance and academic outcomes. 
Coleman received his doctorate in public health with a focus on social and behavioral health science at University of Connecticut, his master’s in public health with a focus on public health policy and management from the Mel and Enid Zuckerman School of Public Health at University of Arizona and his bachelor’s degrees in political science and Spanish from Georgia State University.

 (he/him) studies the effects of nutritional intervention on health outcomes, identifying mechanisms by which nutrients impact gene expression and host physiology, with primary emphasis on gastrointestinal health and obesity. His lab’s research is contributing to the development of diets to help prevent obesity and other health-related issues in humans and animals.
More information: 
Swanson uses genomic biology to study nutrition-related problems in the areas of obesity and intestinal health. Both comparative and applied nutrition research projects are performed in his laboratory, including those studying human subjects, companion animals, and rodent models. A primary aim of his research group is to study the effects of diet and age on gastrointestinal microbiota abundance and activity. DNA-based techniques [e.g., quantitative polymerase chain reaction (qPCR); next-generation sequencing] are used in the lab. Current projects are designed to evaluate the effects of dietary fibers and prebiotics, dietary lipids, and protein: carbohydrate ratio on gastrointestinal microbial populations. Key associations between intestinal microbiota, host physiology, and disease are also being studied. Another primary area of research pertains to energy homeostasis and obesity. Molecular techniques (e.g., qRT-PCR; Fluidigm; RNAseq) are used to identify mechanisms and/or metabolic pathways affected in key metabolic tissues. Adipose tissue and skeletal muscle play important roles in energy homeostasis and glucose and lipid metabolism and are the focus of several ongoing projects.
Affiliations: 
Dr. Swanson is Professor of Animal Nutrition and Nutrigenomics in the  in the  (ACES) at the . He is also interim director of the  at ACES.

Dr. Reece is the Assistant Dean for Student and Professional Affairs, Director of Interprofessional Education, and Associate Professor of Pharmacy Practice, all with the PCOM Georgia School of Pharmacy. She earned her Doctor of Pharmacy degree from Mercer University and completed a community pharmacy residency program with both Mercer University and The Kroger Company. Dr. Reece holds board certification in ambulatory care and advanced diabetes management. She served on the Board of Directors and as Treasurer of the Association of Diabetes Care and Education Specialists. She serves as Chair of the Endocrine and Metabolism PRN of the American College of Clinical Pharmacy and Chair of the Advocacy Committee for ADCES. She also serves as core faculty, ambulatory care pharmacist and diabetes specialist with Northeast Georgia Medical Center Family Medicine Graduate Medical Education Program.
Dr. Reece has a blog, Reece's Pieces in a Diabetes World, and a YouTube channel, ReecesPieces Diabetes. She presents on diabetes and technology related topics nationally.  Dr. Reece was named a 40 under 40 Pharmacist for the Georgia Pharmacy Association (2003), and presented with the Silver Shovel Award by the Greater Hall Chamber of Commerce (2011). She is a Fellow of the Association of Diabetes Care and Education Specialist (2017), an Outstanding Allied Health Professional by the Healthy Hall Greater Hall Chamber of Commerce (2019), a PCOM School of Pharmacy Teacher of the Year for Pharmacy Practice (2019), a PCOM School of Pharmacy Faculty Preceptor of the Year (2022 and 2023), and a Fellow of the American College of Clinical Pharmacy (2022).
 

, is a board-certified obesity medicine physician. As part of UC San Diego Health's , Grunvald evaluates and manages patients before and after surgery, and helps people long-term with their health and weight loss journey. He also directs the , which includes nutrition, behavior, and lifestyle support.
He has extensive experience using medications for weight management.
As a professor in the Univeristy of California San Diego School of Medicine Department of Medicine, Grunvald is very active in teaching on topics such as metabolism, weight regulation, and treatment of obesity and weight-related medical conditions. He serves on a national committee working on standardizing obesity education in medical schools. His research interests include anti-obesity medications, obesity medicine education and bariatric surgery.

Research units
Research expertise



Obesity, prediabetes and type 2 diabetes
Lipoprotein metabolism
Physiology of white adipose tissue
Nutritional interventions
Human studies

Our clinical and fundamental research studies novel mechanisms that may lead to the development of cardiometabolic diseases in humans, such as type 2 diabetes and atherosclerosis. More particularly, we study the role of atherogenic lipoproteins and dysfunctional adipose tissue in this process. Furthermore, we examine the effect of various nutritional interventions as therapeutic tools that could reverse early cardiometabolic abnormalities. These projects will contribute to the prevention of type 2 diabetes in humans, particularly in subjects with obesity.


 Member



 

Adjunct professor, Division of Experimental Medicine, Faculty of Medicine, McGill University
Researcher, Montreal Diabetes Research Center (CRDM)




Professional titles and affiliations

Titles: corporations and professional organizations


Member, Order of Dietitians-Nutritionists of Quebec (ODNQ)


Disciplines

Clinical Sciences
Endocrinology and Metabolism
Nutrition
Biochemistry
Medical Biochemistry
Physiology



Areas of expertise

Obesity
Diabetes
Metabolism
Metabolic Disorders
Metabolic Diseases
Physiology
Nutritional Disorders
Nutrition
Atherosclerosis
Tassels and Fabrics
Lipid Disorders
Menopause
Age and Risk Factors
Cardiovascular Diseases
Health Prevention
Health Promotion
Americas
Canada (Quebec)
2000 AD - Present

I received my Bachelor’s in Kinesiology from the University of Michigan, where I also served as an Assistant Strength and Conditioning Coach with the University of Michigan Football team. I then received a Master’s degree from the University of California, Berkeley, and PhD from the University of Illinois, where I discovered the molecular signal that causes load-induced muscle hypertrophy. I did my postdoctoral studies on the molecular mechanism underlying the muscular adaptation to endurance exercise under the direction of the legendary Dr. John O. Holloszy at Washington University in St. Louis. 
I am currently the head of the Functional Molecular Biology Laboratory (FMBLab) at the University of California Davis. My research is focused on determining the effect of exercise, nutrition, age, and disease on musculoskeletal tissue function. Work from my lab spans from the molecular mechanisms that lead to adaptation to human studies that translate these basic discoveries to interventions that improve longevity and quality of life.

 contributes to the reduction of cardiovascular disease by examining how carotenoids and lipid metabolism interact to mediate atherosclerosis. Using animal models and cell culture techniques, he explores the structure and function of vitamin A and its metabolites to mitigate metabolic disease progression.
More information: Dr. Amengual is from Spain (Palma de Mallorca). He obtained his PhD in 2009 at the University of the Balearic Islands (Spain). He was a post-doctoral fellow at Case Western Reserve University (2009-2013) and at New York University (2013-2015). In 2016 he became a Research Assistant Professor at the School of Medicine – NYU (2016-2017). In 2018, he joined the Department of Food Science and Human Nutrition at the University of Illinois Urbana – Champaign.
Affiliations: Dr. Amengual is an assistant professor of personalized nutrition in the  and the , both part of the  at the . 

Dr. José Ordovás is a senior scientist in precision nutrition at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. His research focuses on the genetic factors that predispose individuals to heart disease and obesity as well as the interaction of these genetic factors with the environment and behavioral factors. In particular, Dr. Ordovás examines the impact of diet on genetic factors. 

As Professor of Medicine and Urology at Yale School of Medicine, Dr. Daniel P. Petrylak is a pioneer in the research and development of new drugs and treatments to fight prostate, bladder, kidney and testicular cancer. For patients fighting these types of cancers, Petrylak finds recent developments in the field of immunotherapy particularly promising. “Up until recently, bladder cancer had not seen any major advancement in more than 30 years,” he says. “Studies are ongoing, but interim results are exciting so far.”
At the Smilow Cancer Hospital, Dr. Petrylak’s position as a national leader on clinical trials for men with prostate and bladder cancer has opened up a world of treatment options for patients in New England. “We offer the latest investigational drugs for these conditions, while providing the highest level of care,” he says.
Dr. Petrylak received his MD from Case Western Reserve University School of Medicine and joined the Yale faculty in 2012. In addition to his role as professor, he is also a member of the Cancer Signaling Networks Research Program at Yale Cancer Center, which studies how cancer stem cells are regulated in the body and communicate with surrounding tissue. Roughly 40 physicians and scientists in the program work together to develop the best methods for matching patients with the appropriate cancer drugs.
One of Dr. Petrylak’s key goals is to continue to successfully translate basic research into clinical practice. “One of the most significant accomplishments in my career was moving docetaxel (an antineoplastic agent) therapy for the most advanced form of prostate cancer from phase I to III,” he says. “We ran a trial which supported its approval for the most advanced form of prostate cancer.”
Dr. Petrylak currently serves as either the principal investigator or co-principal investigator on seven Southwest Oncology Group (SWOG) clinical trials for genitourinary cancers. To date, he has authored more than 100 peer-reviewed articles on prostate and bladder cancer research.

Dr. Joel Mason is Senior Scientist and Leader of the Vitamins and Carcinogenesis Team at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. He studies the cellular pathways by which 1-carbon nutrients, obesity, and the colonic microbiome alter the risk of cancer formation, and his team develops strategies based on this knowledge for the purposes of cancer prevention. Among Dr. Mason’s research accomplishments is the elaboration of cellular mechanisms by which abundant intake of folate protects against colon cancer, insights into how folate availability interacts with certain genetic traits and environmental factors in determining the risk of developing breast and colon cancer, and the demonstration—in both animal models and humans—that obesity incites inflammation and precancerous molecular changes in the lining of the colon. Dr. Mason has authored some of the most frequently cited papers in his field. He has been ranked as a Top Doctor in the U.S. (top 1% of all physicians) and top Cancer Doctor in the U.S. by Castle Connolly Limited, and is consistently rated by his peers as one of the top gastroenterologists in Boston, MA (Boston Magazine) and the U.S. as a whole (U.S. 麻豆传媒 & World Report). He is currently researching the combinations of pharmacologic, dietary, and microbiologic agents in the prevention of obesity-induced colon cancer. Dr. Mason is also a Professor of Medicine at Tufts University School of Medicine and Professor of Nutrition at the Friedman School of Nutrition Science and Policy, and is an Associate Editor of the American Journal of Clinical Nutrition. He is a staff physician in the Divisions of Clinical Nutrition and Gastroenterology at Tufts Medical Center. Dr. Mason is a fellow of the American Gastroenterological Association and a member of the American Association for Cancer Research and American Society for Nutrition.

Wade Van Horn is an assistant professor in the School of Molecular Sciences and is an investigator with the Biodesign Institute's Center for Personalized Diagnostics, and the Magnetic Resonance Research Center. He joined Arizona State University in 2012 after an American Heart Association postdoctoral fellowship at Vanderbilt University School of Medicine in the Department of Biochemistry and the Center for Structural Biology. He received his Ph.D. from the University of Utah's Department of Chemistry. His current interests focus on the interplay between biomolecular function and structure, especially as it relates to human physiology and pathophysiology.



Education

Ph.D. Chemistry, University of Utah 2007